scholarly article | Q13442814 |
P356 | DOI | 10.1016/0264-410X(92)90027-H |
P698 | PubMed publication ID | 1539464 |
P2093 | author name string | B. Meignier | |
F. Vaux-Peretz | |||
J. M. Chapsal | |||
Vaux-Peretz F | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hemagglutinin-neuraminidase | Q12902725 |
P304 | page(s) | 113-118 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice | |
P478 | volume | 10 |
Q36500189 | An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice |
Q49820279 | Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection |
Q37197103 | Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology |
Q33870528 | Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice. |
Q36362647 | Distinct types of lung disease caused by functional subsets of antiviral T cells |
Q36626174 | Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. |
Q45723621 | Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate |
Q37871964 | Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue |
Q40951360 | Immunopathological mechanisms in respiratory syncytial virus disease |
Q40076730 | Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus |
Q83400970 | Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV |
Q36687435 | Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells |
Q35070176 | Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease |
Q35859950 | Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern |
Q36483809 | Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection |
Q45709995 | The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B. |
Q41511965 | The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies |
Q45353912 | The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease |
Search more.